![David Fisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fisher
Direttore/Membro del Consiglio presso
Australian Biomedical Fund No. 1 Ltd.
Profilo
David M.
Fisher is currently a Director at Australian Biotechnology & Healthcare Fund No.
3 Ltd., Australian Biomedical Fund No.
1 Ltd., and Australian Biomedical Fund No.
2 Ltd. He is a Venture Partner at Brandon Capital Partners Pty Ltd. since 2006 and a Member of AusBiotech Ltd. Formerly, Dr. Fisher was Chief Executive Officer at Arana Therapeutics Ltd., GI Therapies Pty Ltd., and Cephalon LLC.
He served as Non-Executive Director at Aeris Environmental Ltd. from 2013 to 2014, and also held Non-Executive Director roles at Signostics Ltd. and Director at Global Kinetics Pty Ltd. From 2012 to 2024, he was an Independent Non-Executive Director at Nanosonics Ltd. Education includes undergraduate and doctorate degrees from The University of Sydney.
Posizioni attive di David Fisher
| Società | Posizione | Inizio |
|---|---|---|
Australian Biomedical Fund No. 1 Ltd.
 Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direttore/Membro del Consiglio | - |
Australian Biomedical Fund No. 2 Ltd.
 Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direttore/Membro del Consiglio | - |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
 Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direttore/Membro del Consiglio | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Corporate Officer/Principal | - |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/09/2006 |
Precedenti posizioni note di David Fisher
| Società | Posizione | Fine |
|---|---|---|
| NANOSONICS LIMITED | Direttore/Membro del Consiglio | 12/11/2024 |
| AERIS ENVIRONMENTAL LTD | Presidente | 29/03/2013 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Amministratore Delegato | - |
GI Therapies Pty Ltd.
 GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Amministratore Delegato | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di David Fisher
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Nanosonics Ltd.
 Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Arana Therapeutics Ltd.
 Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals; researches medical diagnostic products | Health Technology |
Aeris Environmental Ltd.
 Aeris Environmental Ltd. Household/Personal CareConsumer Non-Durables Manufactures and distributes cleaning products | Consumer Non-Durables |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Signostics Ltd.
 Signostics Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for neurology and provides related services | Health Technology |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Health Technology |
